Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CASP1 | P29466 | 1/20 | 0.33 |
| ▸ | CASP7 | P55210 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.32 |
| ▸ | FLT3 | P36888 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | ACACA | Q13085 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19104572 | 0.96 | DUSP3 (0.33) | KDM4EMAPK1ALDH1A1HPGDTSHR | |
| SCHEMBL15625642 | 0.96 | DUSP3 (0.33) | KDM4EMAPK1ALDH1A1HPGDTSHR | |
| SCHEMBL12698479 | 0.96 | DUSP3 (0.34) | KDM4EMAPK1ALDH1A1HPGDTSHR | |
| SCHEMBL18505564 | 0.94 | DUSP3 (0.32) | KDM4EMAPK1ALDH1A1HPGDTSHR | |
| SCHEMBL16406777 | 0.92 | PTGER4 (0.33) | KDM4EMAPK1ALDH1A1HPGDTSHR | |
| SCHEMBL16406748 | 0.92 | KDM4E (0.33) | KDM4EMAPK1ALDH1A1HPGDTSHR | |
| SCHEMBL17427633 | 0.91 | DUSP3 (0.34) | KDM4EMAPK1ALDH1A1HPGDTSHR | |
| SCHEMBL16406747 | 0.91 | PTGER4 (0.33) | KDM4EMAPK1ALDH1A1HPGDTSHR | |
| SCHEMBL24994899 | 0.90 | MEN1 (0.35) | KDM4EMAPK1ALDH1A1HPGDTSHR | |
| SCHEMBL15625650 | 0.90 | DUSP3 (0.32) | DUSP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE49237-E1 | Organic electroluminescence device and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2022-10-04 | — | — | US | disclosed |
| US-20170200904-A1 | AN ORGANIC ELECTROLUMINESCENT COMPOUND AND AN ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) | 2017-07-13 | — | — | US | disclosed |
| US-20170200904-A1 | AN ORGANIC ELECTROLUMINESCENT COMPOUND AND AN ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) | 2017-07-13 | — | — | US | disclosed |
| US-9397307-B2 | Organic electroluminescence device and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2016-07-19 | — | — | US | disclosed |
| US-9397307-B2 | Organic electroluminescence device and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2016-07-19 | — | — | US | disclosed |
| US-20150025239-A1 | NOVEL ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | AHN HEE-CHOON (KR) | 2015-01-22 | — | — | US | disclosed |
| US-20150025239-A1 | NOVEL ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | AHN HEE-CHOON (KR) | 2015-01-22 | — | — | US | disclosed |
| US-20140231769-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2014-08-21 | — | — | US | disclosed |
| US-20140231769-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2014-08-21 | — | — | US | disclosed |
| US-20140084270-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2014-03-27 | — | — | US | disclosed |
| US-20140084270-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2014-03-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170200904-A1 | AN ORGANIC ELECTROLUMINESCENT COMPOUND AND AN ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | TERT, ODC1, ESD | KDM4E 815/4885MAPK1 3706/4885ALDH1A1 445/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.